Manulife Q2 2007 Earnings

Financial Post, Grant Surridge, 10 August 2007"This quarter demonstrates the strength of MFC's distribution capabilities, product innovation and brand quality, as sales rose in a number of key lines," wrote UBS Investment Research analyst Jason Bilodeau, who rates the stock a 'buy' with a 12-month target price of $47.He thinks the stock has underperformed so far this year "amid broader weakness,"